Lexicon Pharmaceuticals, Inc.
USE OF SOTAGLIFLOZIN FOR THE TREATMENT OF PATIENTS WITH TYPE 1 DIABETES MELLITUS
Last updated:
Abstract:
The invention relates to the use of sotagliflozin to improve glycemic control in adults with type 1 diabetes mellitus with a Body Mass Index (BMI).gtoreq.27 kg/m.sup.2.
Status:
Application
Type:
Utility
Filling date:
28 Feb 2020
Issue date:
11 Feb 2021